重大资产重组！大牛股，今日复牌！

Group 1: Core Views - Multiple A-shares are set to resume trading, including Dongtu Technology and Weigao Blood Purification, following significant asset restructuring announcements [1][5] - Dongtu Technology plans to acquire 100% of Gaoweike, with the transaction expected to meet the criteria for a major asset restructuring [2][4] - Weigao Blood Purification intends to purchase 100% of Weigao Puri, also anticipated to constitute a major asset restructuring [5][6] Group 2: Dongtu Technology - Dongtu Technology will issue shares and pay cash to acquire Gaoweike, which will become a wholly-owned subsidiary post-transaction [2] - The share issuance price is set at 18.56 yuan per share, representing 80% of the average trading price over the previous 120 trading days [2] - The acquisition aims to enhance Dongtu's capabilities in providing comprehensive solutions and improve its market competitiveness [4] Group 3: Gaoweike Overview - Gaoweike, established in 2001, specializes in industrial automation and control systems, serving various manufacturing sectors [3] - The company has developed core products in motion control, including PLCs and servo systems, and has a broad customer base across China [3] Group 4: Weigao Blood Purification - Weigao Blood Purification's acquisition of Weigao Puri will expand its product line into pre-filled drug delivery systems and automatic safety delivery systems [7] - The company reported a total revenue of 2.736 billion yuan for the first three quarters of the year, reflecting a year-on-year growth of 3.45% [7]